589 related articles for article (PubMed ID: 21088399)
1. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
Ozbek B; Sentürk A
Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Ozbek B; Otük G
Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
[No Abstract] [Full Text] [Related]
3. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
Candel FJ; Calvo N; Head J; Sánchez A; Matesanz M; Culebras E; Barrientos A; Picazo J
Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii.
Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D
J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
10. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
Al-Sweih NA; Al-Hubail MA; Rotimi VO
J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
Capone A; D'Arezzo S; Visca P; Petrosillo N;
J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
[No Abstract] [Full Text] [Related]
15. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
Seifert H; Stefanik D; Wisplinghoff H
J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
[No Abstract] [Full Text] [Related]
16. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
[TBL] [Abstract][Full Text] [Related]
18. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline and colistin against A. baumannii clinical bloodstream isolates during an 8-year period.
Spiliopoulou A; Jelastopulu E; Vamvakopoulou S; Bartzavali C; Kolonitsiou F; Anastassiou ED; Christofidou M
J Chemother; 2015 Oct; 27(5):266-70. PubMed ID: 24827985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
